SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-04-01 15:54
Tx date 2025-03-31 		$ABUS
Arbutus Biopharma Corporation 		Nguyen, Tuan
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,617,500
+750,000 vol
$3.49 each 		750,000
Filed 2025-04-01 15:48
Tx date 2025-03-28 		$ABUS
Arbutus Biopharma Corporation 		Nguyen, Tuan
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-04-01 15:48
Tx date 2025-03-28 		$ABUS
Arbutus Biopharma Corporation 		Nguyen, Tuan
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-20 18:16
Tx date 2025-03-18 		$ABUS
Arbutus Biopharma Corporation 		Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$993,350
+310,422 vol
$3.20 each 		310,422
Filed 2025-03-20 18:13
Tx date 2025-03-18 		$ABUS
Arbutus Biopharma Corporation 		Hasija, Anuj
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$504,320
+157,600 vol
$3.20 each 		157,600
Filed 2025-03-20 18:10
Tx date 2025-03-18 		$ABUS
Arbutus Biopharma Corporation 		Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$504,320
+157,600 vol
$3.20 each 		157,600
Filed 2025-03-06 17:00
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Matthew, Gline
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:59
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Matthew, Gline
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:59
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Matthew, Gline
4 - Director of Issuer
Holder: Roivant Sciences Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		38,847,462
Filed 2025-03-06 16:43
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:42
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Androski, Lindsay
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:41
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:41
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Beardsley, Robert Alan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:39
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Bishop, Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:39
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Bishop, Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:33
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Hasija, Anuj
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-06 16:32
Tx date 2025-02-25 		$ABUS
Arbutus Biopharma Corporation 		Hasija, Anuj
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-02-27 15:08
Tx date 2021-10-18 		$ABUS
Arbutus Biopharma Corporation 		Roivant Sciences Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
+22,833,922 vol 		38,847,462
Filed 2025-02-27 15:07
Tx date 2021-10-18 		$ABUS
Arbutus Biopharma Corporation 		Roivant Sciences Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Preferred Shares Series A
36 - Conversion or exchange
-1,164,000 vol 		0
Filed 2025-02-20 12:57
Tx date 2024-12-31 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$4,309
+2,477 vol
$1.74 each 		97,577
Filed 2025-02-19 20:20
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$658,987
+200,300 vol
$3.29 each 		1,046,400
Filed 2025-02-19 20:18
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+49,300 vol 		155,494
Filed 2025-02-19 20:17
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$724,787
+220,300 vol
$3.29 each 		1,100,800
Filed 2025-02-19 20:16
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+54,300 vol 		138,067
Filed 2025-02-19 20:10
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,364,852
+718,800 vol
$3.29 each 		2,494,218
Filed 2025-02-19 20:09
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+177,000 vol 		1,658,003
Filed 2025-02-19 20:02
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,203,482
+365,800 vol
$3.29 each 		2,104,300
Filed 2025-02-19 19:43
Tx date 2025-02-14 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+90,100 vol 		249,824
Filed 2025-02-05 17:39
Tx date 2025-02-04 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-37,206.239
-11,333 vol
$3.28 each 		83,767
Filed 2025-02-05 17:19
Tx date 2025-02-04 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-63,519.484
-19,348 vol
$3.28 each 		106,194
Filed 2025-02-05 17:16
Tx date 2025-02-04 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-78,102.57
-23,790 vol
$3.28 each 		1,481,003
Filed 2025-02-05 16:34
Tx date 2025-02-04 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-72,826.789
-22,183 vol
$3.28 each 		159,724
Filed 2024-08-19 23:20
Tx date 2015-03-04 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		46,069
Filed 2024-08-19 23:10
Tx date 2024-08-14 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
51 - Exercise of options
-54,915 vol 		288,000
Filed 2024-05-31 16:08
Tx date 2024-05-23 		$ABUS
Arbutus Biopharma Corporation 		Rewolinski, Melissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$219,760
+67,000 vol
$3.28 each 		177,000
Filed 2024-05-31 16:05
Tx date 2023-07-12 		$ABUS
Arbutus Biopharma Corporation 		Rewolinski, Melissa
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$249,700
+110,000 vol
$2.27 each 		110,000
Filed 2024-05-31 16:02
Tx date 2023-07-11 		$ABUS
Arbutus Biopharma Corporation 		Rewolinski, Melissa
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2024-05-24 18:52
Tx date 2024-05-23 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$219,760
+67,000 vol
$3.28 each 		273,000
Filed 2024-05-24 18:50
Tx date 2024-05-23 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$219,760
+67,000 vol
$3.28 each 		303,000
Filed 2024-05-24 18:48
Tx date 2024-05-23 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$219,760
+67,000 vol
$3.28 each 		323,000
Filed 2024-05-24 18:44
Tx date 2024-05-23 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$219,760
+67,000 vol
$3.28 each 		273,000
Filed 2024-05-24 15:11
Tx date 2024-05-23 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+67,000 vol 		342,915
Filed 2024-03-12 14:44
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-10,077.875
-4,358 vol
$2.31 each 		125,542
Filed 2024-03-12 14:42
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+101,000 vol 		129,900
Filed 2024-03-12 14:41
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$969,360
+403,900 vol
$2.40 each 		846,100
Filed 2024-03-12 14:33
Tx date 2023-07-10 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		442,200
Filed 2024-03-12 14:29
Tx date 2023-07-10 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		28,900
Filed 2024-03-12 14:20
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$913,200
+380,500 vol
$2.40 each 		880,500
Filed 2024-03-12 14:17
Tx date 2023-07-10 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		500,000
Filed 2024-03-12 14:12
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+95,100 vol 		95,100
Filed 2024-03-12 13:57
Tx date 2023-07-10 		$ABUS
Arbutus Biopharma Corporation 		Naftzger, Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-03-12 13:37
Tx date 2023-07-10 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-03-12 13:37
Tx date 2023-07-10 		$ABUS
Arbutus Biopharma Corporation 		Sims, Karen
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-02-05 21:46
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,188,240
+495,100 vol
$2.40 each 		1,775,418
Filed 2024-02-05 21:45
Tx date 2024-02-02 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,504.25
-10,164 vol
$2.31 each 		1,504,793
Filed 2024-02-05 21:44
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+123,800 vol 		1,514,957
Filed 2024-02-05 21:18
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,050,720
+437,800 vol
$2.40 each 		2,146,500
Filed 2024-02-05 21:15
Tx date 2024-02-02 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-23,083.375
-9,982 vol
$2.31 each 		1,735,121
Filed 2024-02-05 21:10
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+109,500 vol 		1,745,103
Filed 2024-02-05 20:52
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,080,000
+450,000 vol
$2.40 each 		1,738,500
Filed 2024-02-05 20:49
Tx date 2024-02-02 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-22,183.8125
-9,593 vol
$2.31 each 		181,907
Filed 2024-02-05 20:44
Tx date 2024-02-01 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+112,500 vol 		191,500
Filed 2023-05-26 22:32
Tx date 2023-05-24 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+55,000 vol 		275,915
Filed 2023-05-26 17:29
Tx date 2023-05-24 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$140,800
+55,000 vol
$2.56 each 		236,000
Filed 2023-05-26 17:28
Tx date 2023-05-24 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$140,800
+55,000 vol
$2.56 each 		256,000
Filed 2023-05-26 17:25
Tx date 2023-05-24 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$140,800
+55,000 vol
$2.56 each 		206,000
Filed 2023-05-26 17:23
Tx date 2023-05-24 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$140,800
+55,000 vol
$2.56 each 		206,000
Filed 2023-02-06 20:29
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+82,200 vol 		1,635,603
Filed 2023-02-06 20:20
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$953,230
+328,700 vol
$2.90 each 		1,708,700
Filed 2023-02-06 20:10
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$970,630
+334,700 vol
$2.90 each 		1,280,318
Filed 2023-02-06 20:08
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+83,700 vol 		1,391,157
Filed 2023-02-06 20:06
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$916,400
+316,000 vol
$2.90 each 		1,288,500
Filed 2023-02-06 20:01
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+79,000 vol 		79,000
Filed 2023-02-06 20:00
Tx date 2018-06-11 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-02-06 19:58
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$808,230
+278,700 vol
$2.90 each 		1,328,200
Filed 2023-02-06 19:56
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+69,700 vol 		69,700
Filed 2023-02-06 19:49
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,511,400
+866,000 vol
$2.90 each 		4,139,950
Filed 2023-02-06 19:44
Tx date 2023-02-01 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Common Shares
56 - Grant of rights
+216,500 vol 		216,500
Filed 2023-02-06 08:26
Tx date 2019-06-24 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-26 22:11
Tx date 2022-05-25 		$ABUS
Arbutus Biopharma Corporation 		Tran, Tram
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$92,250
+41,000 vol
$2.25 each 		85,000
Filed 2022-05-26 22:09
Tx date 2022-05-25 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$92,250
+41,000 vol
$2.25 each 		181,000
Filed 2022-05-26 22:05
Tx date 2022-05-25 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$92,250
+41,000 vol
$2.25 each 		151,000
Filed 2022-05-26 22:02
Tx date 2022-05-25 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$92,250
+41,000 vol
$2.25 each 		201,000
Filed 2022-05-26 22:00
Tx date 2022-05-25 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$92,250
+41,000 vol
$2.25 each 		151,000
Filed 2022-05-26 19:50
Tx date 2022-05-25 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+41,000 vol 		220,915
Filed 2022-01-20 18:30
Tx date 2022-01-20 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$800,850
+285,000 vol
$2.81 each 		1,380,000
Filed 2022-01-20 18:28
Tx date 2022-01-20 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$720,765
+256,500 vol
$2.81 each 		1,044,000
Filed 2022-01-20 18:25
Tx date 2022-01-20 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$915,638
+325,850 vol
$2.81 each 		945,618
Filed 2022-01-20 18:22
Tx date 2022-01-20 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$667,375
+237,500 vol
$2.81 each 		1,049,500
Filed 2022-01-20 18:19
Tx date 2022-01-20 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$800,850
+285,000 vol
$2.81 each 		972,500
Filed 2022-01-20 18:15
Tx date 2022-01-20 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,213,015
+787,550 vol
$2.81 each 		3,273,950
Filed 2021-11-12 15:22
Tx date 2021-11-09 		$ABUS
Arbutus Biopharma Corporation 		Tran, Tram
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$154,000
+44,000 vol
$3.50 each 		44,000
Filed 2021-11-12 15:18
Tx date 2021-11-09 		$ABUS
Arbutus Biopharma Corporation 		Tran, Tram
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-07 21:53
Tx date 2021-06-03 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+22,000 vol 		179,915
Filed 2021-06-07 20:27
Tx date 2021-06-03 		$ABUS
Arbutus Biopharma Corporation 		Cheng, Andrew Kaiche
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$64,900
+22,000 vol
$2.95 each 		104,000
Filed 2021-06-07 20:26
Tx date 2021-06-03 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$64,900
+22,000 vol
$2.95 each 		110,000
Filed 2021-06-07 20:24
Tx date 2021-06-03 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$64,900
+22,000 vol
$2.95 each 		140,000
Filed 2021-06-07 20:22
Tx date 2021-06-03 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$64,900
+22,000 vol
$2.95 each 		110,000
Filed 2021-06-07 20:20
Tx date 2021-06-03 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$64,900
+22,000 vol
$2.95 each 		160,000
Filed 2021-02-18 09:51
Tx date 2021-02-13 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$866,000
+200,000 vol
$4.33 each 		812,000
Filed 2021-02-18 09:50
Tx date 2021-02-13 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,922,750
+675,000 vol
$4.33 each 		2,486,400
Filed 2021-02-18 09:20
Tx date 2021-02-13 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,078,170
+249,000 vol
$4.33 each 		619,768
Filed 2021-02-18 09:18
Tx date 2021-02-13 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,255,700
+290,000 vol
$4.33 each 		1,095,000
Filed 2021-02-18 09:15
Tx date 2021-02-13 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,082,500
+250,000 vol
$4.33 each 		787,500
Filed 2021-02-18 07:57
Tx date 2021-02-13 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,082,500
+250,000 vol
$4.33 each 		687,500
Filed 2021-02-10 17:19
Tx date 2021-02-09 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-100,000
-20,000 vol
$5.00 each 		1,307,457
Filed 2020-12-16 17:14
Tx date 2020-12-14 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-200,000
-40,000 vol
$5.00 each 		1,327,457
Filed 2020-09-25 16:11
Tx date 2020-09-23 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$167,500
+50,000 vol
$3.35 each 		537,500
Filed 2020-09-25 16:07
Tx date 2020-09-23 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$234,500
+70,000 vol
$3.35 each 		1,811,400
Filed 2020-07-29 14:12
Tx date 2020-07-23 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-100,200
-20,000 vol
$5.01 each 		1,367,457
Filed 2020-06-01 17:51
Tx date 2020-05-28 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$878,748
+262,313 vol
$3.35 each 		1,741,400
Filed 2020-06-01 17:44
Tx date 2020-05-28 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,520
+22,000 vol
$2.16 each 		118,000
Filed 2020-06-01 17:41
Tx date 2020-05-28 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,520
+22,000 vol
$2.16 each 		88,000
Filed 2020-06-01 17:37
Tx date 2020-05-28 		$ABUS
Arbutus Biopharma Corporation 		Cheng, Andrew Kaiche
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,520
+22,000 vol
$2.16 each 		82,000
Filed 2020-06-01 17:35
Tx date 2020-05-28 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,520
+22,000 vol
$2.16 each 		88,000
Filed 2020-06-01 17:31
Tx date 2020-05-28 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$47,520
+22,000 vol
$2.16 each 		138,000
Filed 2020-05-29 11:20
Tx date 2020-05-28 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+22,000 vol 		157,915
Filed 2020-02-19 15:28
Tx date 2020-02-18 		$ABUS
Arbutus Biopharma Corporation 		Venker, Eric
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-19 14:56
Tx date 2020-02-17 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+79,500 vol 		612,000
Filed 2020-02-19 14:54
Tx date 2020-02-17 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+250,000 vol 		805,000
Filed 2020-02-19 14:52
Tx date 2020-02-17 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		370,768
Filed 2020-02-19 14:42
Tx date 2020-02-17 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+150,000 vol 		487,500
Filed 2020-02-19 14:40
Tx date 2020-02-17 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+100,000 vol 		437,500
Filed 2020-02-19 14:37
Tx date 2020-02-17 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+367,087 vol 		1,479,087
Filed 2019-08-23 10:33
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+22,000 vol 		135,915
Filed 2019-08-22 17:12
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Potter, Myrtle Stephens
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,000
+22,000 vol
$1.50 each 		66,000
Filed 2019-08-22 12:55
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,000
+22,000 vol
$1.50 each 		66,000
Filed 2019-08-20 16:47
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Cheng, Andrew Kaiche
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$90,000
+60,000 vol
$1.50 each 		60,000
Filed 2019-08-20 16:43
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Cheng, Andrew Kaiche
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-20 16:31
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,000
+22,000 vol
$1.50 each 		66,000
Filed 2019-08-20 16:30
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,000
+22,000 vol
$1.50 each 		96,000
Filed 2019-08-20 16:28
Tx date 2019-08-17 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,000
+22,000 vol
$1.50 each 		116,000
Filed 2019-06-27 13:13
Tx date 2019-06-24 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,424,160
+1,112,000 vol
$2.18 each 		1,112,000
Filed 2019-06-27 13:10
Tx date 2019-06-24 		$ABUS
Arbutus Biopharma Corporation 		Collier, William Hugh
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-03-05
Tx date 2019-03-01 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$628,375
+137,500 vol
$4.57 each 		337,500
Filed 2019-03-05
Tx date 2019-03-01 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$662,650
+145,000 vol
$4.57 each 		555,000
Filed 2019-03-05
Tx date 2019-03-01 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$628,375
+137,500 vol
$4.57 each 		337,500
Filed 2019-03-05
Tx date 2019-03-01 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,633,775
+357,500 vol
$4.57 each 		2,120,687
Filed 2019-03-05
Tx date 2019-03-01 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$628,375
+137,500 vol
$4.57 each 		532,500
Filed 2019-03-05
Tx date 2019-03-01 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$477,565
+104,500 vol
$4.57 each 		170,768
Filed 2018-12-21
Tx date 2018-12-11 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,387,457
Filed 2018-12-21
Tx date 2018-12-11 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		66,268
Filed 2018-12-21
Tx date 2018-12-11 		$ABUS
Arbutus Biopharma Corporation 		McElhaugh, Michael John
5 - Senior Officer of Issuer
Holder: Michael J. McElhaugh Irrevocable Trust (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		377,358
Filed 2018-12-14
Tx date 2018-12-11 		$ABUS
Arbutus Biopharma Corporation 		Koert VandenEnden, Koert VandenEnden
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,300
+7,500 vol
$4.44 each 		82,500
Filed 2018-11-29
Tx date 2018-11-28 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$45,000
+25,000 vol
$1.80 each
Filed 2018-11-29
Tx date 2018-08-30 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
-30,000 vol 		1,788,187
Filed 2018-11-29
Tx date 2018-11-28 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-45,000
-25,000 vol
$1.80 each 		1,763,187
Filed 2018-11-29
Tx date 2018-04-17 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-12,001.9108
-27,007 vol
$0.4444 each 		1,818,187
Filed 2018-11-29
Tx date 2018-04-17 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$12,001
+27,007 vol
$0.4444 each 		316,396
Filed 2018-11-28
Tx date 2018-11-28 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$45,000
+25,000 vol
$1.80 each 		1,870,194
Filed 2018-11-28
Tx date 2018-11-28 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$45,000
+25,000 vol
$1.80 each 		314,389
Filed 2018-11-26
Tx date 2018-11-26 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26
Tx date 2018-11-26 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-26
Tx date 2018-11-26 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$207,680
+44,000 vol
$4.72 each 		44,000
Filed 2018-11-26
Tx date 2018-11-26 		$ABUS
Arbutus Biopharma Corporation 		Torti, Frank
4 - Director of Issuer
Direct Ownership
Convertible Preferred Shares Series A
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Potter, Myrtle Stephens
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Potter, Myrtle Stephens
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Potter, Myrtle Stephens
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$207,240
+44,000 vol
$4.71 each 		44,000
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Potter, Myrtle Stephens
4 - Director of Issuer
Direct Ownership
Convertible Preferred Shares Series A
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Convertible Preferred Shares Series A
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-14
Tx date 2018-10-18 		$ABUS
Arbutus Biopharma Corporation 		Meyers, James Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$207,240
+44,000 vol
$4.71 each 		44,000
Filed 2018-10-10
Tx date 2018-10-08 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-10
Tx date 2018-10-08 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Convertible Preferred Shares Series A
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-10
Tx date 2018-10-08 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,876,000
+200,000 vol
$9.38 each 		200,000
Filed 2018-10-10
Tx date 2018-10-08 		$ABUS
Arbutus Biopharma Corporation 		PICCHIO, GASTON RAFAEL
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-22
Tx date 2018-06-19 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$148,500
+22,000 vol
$6.75 each 		74,000
Filed 2018-06-22
Tx date 2018-06-19 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$148,500
+22,000 vol
$6.75 each 		94,000
Filed 2018-06-22
Tx date 2018-06-19 		$ABUS
Arbutus Biopharma Corporation 		Conrad, Herbert Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$148,500
+22,000 vol
$6.75 each 		74,000
Filed 2018-06-22
Tx date 2018-06-19 		$ABUS
Arbutus Biopharma Corporation 		Ramaswamy, Vivek
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$148,500
+22,000 vol
$6.75 each 		59,000
Filed 2018-06-21
Tx date 2018-06-11 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-06-21
Tx date 2018-06-19 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+22,000 vol 		113,915
Filed 2018-06-21
Tx date 2018-06-19 		$ABUS
Arbutus Biopharma Corporation 		Hastings, David Cummins
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,350,000
+200,000 vol
$6.75 each 		200,000
Filed 2018-04-17
Tx date 2018-04-16 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$780,000
+150,000 vol
$5.20 each 		395,000
Filed 2018-04-17
Tx date 2018-04-16 		$ABUS
Arbutus Biopharma Corporation 		Symonds, III, William Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$156,000
+30,000 vol
$5.20 each 		105,000
Filed 2018-04-17
Tx date 2018-04-16 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$832,000
+160,000 vol
$5.20 each 		410,000
Filed 2018-04-17
Tx date 2018-04-16 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,174,572
+418,187 vol
$5.20 each 		1,845,194
Filed 2018-04-17
Tx date 2018-04-16 		$ABUS
Arbutus Biopharma Corporation 		Koert VandenEnden, Koert VandenEnden
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$130,000
+25,000 vol
$5.20 each 		75,000
Filed 2018-02-16
Tx date 2018-02-13 		$ABUS
Arbutus Biopharma Corporation 		Koert VandenEnden, Koert VandenEnden
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2018-02-16
Tx date 2018-02-13 		$ABUS
Arbutus Biopharma Corporation 		Koert VandenEnden, Koert VandenEnden
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,750
Filed 2018-01-16
Tx date 2018-01-12 		$ABUS
Arbutus Biopharma Corporation 		Roivant Sciences, Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Preferred Shares Series A
11 - Acquisition or disposition carried out privately 		$66,400,000
+664,000 vol
$100.00 each 		1,164,000
Filed 2017-10-25
Tx date 2017-10-21 		$ABUS
Arbutus Biopharma Corporation 		Karbe, Lutz Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$87,780
+22,000 vol
$3.99 each 		74,500
Filed 2017-10-25
Tx date 2017-10-21 		$ABUS
Arbutus Biopharma Corporation 		Ramaswamy, Vivek
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$78,100
+22,000 vol
$3.55 each 		37,000
Filed 2017-10-20
Tx date 2015-03-04 		$ABUS
Arbutus Biopharma Corporation 		Roivant Sciences, Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Preferred Shares Series A
00 - Opening Balance-Initial SEDI Report
Filed 2017-10-20
Tx date 2017-10-16 		$ABUS
Arbutus Biopharma Corporation 		Roivant Sciences, Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Convertible Preferred Shares Series A
11 - Acquisition or disposition carried out privately 		$50,000,000
+500,000 vol
$100.00 each 		500,000
Filed 2017-10-04
Tx date 2017-10-03 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
-10,000 vol 		1,553,403
Filed 2017-08-16
Tx date 2017-08-15 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Holder: Irrevocable Deed of Trust of Michael J. Sofia (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
-30,000 vol 		171,412
Filed 2017-06-22
Tx date 2017-06-21 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$78,100
+22,000 vol
$3.55 each 		52,000
Filed 2017-06-22
Tx date 2017-06-21 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$78,100
+22,000 vol
$3.55 each 		72,000
Filed 2017-06-22
Tx date 2017-06-21 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+22,000 vol 		91,915
Filed 2017-06-22
Tx date 2017-06-21 		$ABUS
Arbutus Biopharma Corporation 		Conrad, Herbert Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$78,100
+22,000 vol
$3.55 each 		52,000
Filed 2017-04-04
Tx date 2017-03-24 		$ABUS
Arbutus Biopharma Corporation 		Symonds, III, William Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$157,500
+50,000 vol
$3.15 each 		75,000
Filed 2017-04-03
Tx date 2017-03-01 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants 		$-13,000
-5,000 vol
$2.60 each 		0
Filed 2017-04-03
Tx date 2017-03-24 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,417,500
+450,000 vol
$3.15 each 		1,427,007
Filed 2017-04-03
Tx date 2017-03-01 		$ABUS
Arbutus Biopharma Corporation 		Lutwyche, Peter
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants 		$-6,500
-2,500 vol
$2.60 each 		0
Filed 2017-04-03
Tx date 2017-03-24 		$ABUS
Arbutus Biopharma Corporation 		Lutwyche, Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$393,750
+125,000 vol
$3.15 each 		310,000
Filed 2017-04-03
Tx date 2017-03-24 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$393,750
+125,000 vol
$3.15 each 		245,000
Filed 2017-04-03
Tx date 2017-03-24 		$ABUS
Arbutus Biopharma Corporation 		Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$630,000
+200,000 vol
$3.15 each 		650,000
Filed 2017-04-03
Tx date 2017-03-01 		$ABUS
Arbutus Biopharma Corporation 		Karbe, Lutz Frank
4 - Director of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants 		$-6,500
-2,500 vol
$2.60 each 		0
Filed 2017-04-03
Tx date 2017-03-24 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$472,500
+150,000 vol
$3.15 each 		250,000
Filed 2017-03-28
Tx date 2017-03-24 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$157,500
+50,000 vol
$3.15 each 		50,000
Filed 2017-03-28
Tx date 2017-03-23 		$ABUS
Arbutus Biopharma Corporation 		Burgess, Daniel Dean
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-08-18
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-299.97
-675 vol
$0.4444 each
Filed 2016-08-18
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$6,000
+13,503 vol
$0.4444 each 		249,178
Filed 2016-08-18
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-6,000.7332
-13,503 vol
$0.4444 each
Filed 2016-08-18
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$299.97
+675 vol
$0.4444 each 		235,675
Filed 2016-08-17
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-6,000.7332
-13,503 vol
$0.4444 each 		235,000
Filed 2016-08-17
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-6,000.7332
-13,503 vol
$0.4444 each 		220,822
Filed 2016-08-17
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-299.97
-675 vol
$0.4444 each 		234,325
Filed 2016-08-17
Tx date 2016-08-16 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-299.97
-675 vol
$0.4444 each 		248,503
Filed 2016-06-21
Tx date 2016-06-16 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-16,750
-5,000 vol
$3.35 each 		5,000
Filed 2016-06-21
Tx date 2016-06-16 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$16,750
+5,000 vol
$3.35 each 		289,389
Filed 2016-06-07
Tx date 2016-06-03 		$ABUS
Arbutus Biopharma Corporation 		Ramaswamy, Vivek
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options 		$29,925
+7,500 vol
$3.99 each 		15,000
Filed 2016-06-06
Tx date 2016-06-03 		$ABUS
Arbutus Biopharma Corporation 		Manchester, Keith Simon
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
+7,500 vol 		69,915
Filed 2016-06-03
Tx date 2016-06-03 		$ABUS
Arbutus Biopharma Corporation 		Karbe, Lutz Frank
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$29,925
+7,500 vol
$3.99 each 		52,500
Filed 2016-06-03
Tx date 2016-06-03 		$ABUS
Arbutus Biopharma Corporation 		Conrad, Herbert Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$29,925
+7,500 vol
$3.99 each 		30,000
Filed 2016-06-03
Tx date 2016-06-03 		$ABUS
Arbutus Biopharma Corporation 		Henriques, Richard Conover
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$29,925
+7,500 vol
$3.99 each 		30,000
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Symonds, III, William Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$98,500
+25,000 vol
$3.94 each 		25,000
Filed 2016-03-29
Tx date 2015-03-04 		$ABUS
Arbutus Biopharma Corporation 		Symonds, III, William Thomas
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-29
Tx date 2016-01-01 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-2,419.758
-5,445 vol
$0.4444 each 		199,178
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Abrams, Michael Jeffery
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$197,000
+50,000 vol
$3.94 each 		249,178
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Cousins, Bruce Gordon
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$571,300
+145,000 vol
$3.94 each 		450,000
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$472,800
+120,000 vol
$3.94 each 		120,000
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Kowalski, Mark Marion
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$334,900
+85,000 vol
$3.94 each 		260,000
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Lutwyche, Peter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$236,400
+60,000 vol
$3.94 each 		185,000
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Murray, Mark Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,773,000
+450,000 vol
$3.94 each 		977,007
Filed 2016-03-29
Tx date 2015-03-04 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-29
Tx date 2016-03-15 		$ABUS
Arbutus Biopharma Corporation 		Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$394,000
+100,000 vol
$3.94 each 		100,000
Filed 2016-03-11
Tx date 2016-03-07 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-11
Tx date 2016-03-07 		$ABUS
Arbutus Biopharma Corporation 		Howard, Elizabeth Ann
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report